Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 1
2010 1
2011 2
2012 2
2013 4
2014 4
2015 2
2016 3
2017 2
2018 5
2019 4
2020 4
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
Anaplastic large-cell lymphoma.
Inghirami G, Pileri SA; European T-Cell Lymphoma Study Group. Inghirami G, et al. Semin Diagn Pathol. 2011 Aug;28(3):190-201. doi: 10.1053/j.semdp.2011.03.002. Semin Diagn Pathol. 2011. PMID: 21850985 Review.
Transposable elements: The enemies within.
Scarfò I, Pellegrino E, Mereu E, Inghirami G, Piva R. Scarfò I, et al. Among authors: pellegrino e. Exp Hematol. 2016 Oct;44(10):913-6. doi: 10.1016/j.exphem.2016.06.251. Epub 2016 Jul 1. Exp Hematol. 2016. PMID: 27377925 Review.
The heterogeneous landscape of ALK negative ALCL.
Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R. Mereu E, et al. Among authors: pellegrino e. Oncotarget. 2017 Mar 14;8(11):18525-18536. doi: 10.18632/oncotarget.14503. Oncotarget. 2017. PMID: 28061468 Free PMC article. Review.
Anaplastic lymphoma kinase in human cancer.
Barreca A, Lasorsa E, Riera L, Machiorlatti R, Piva R, Ponzoni M, Kwee I, Bertoni F, Piccaluga PP, Pileri SA, Inghirami G; European T-Cell Lymphoma Study Group. Barreca A, et al. J Mol Endocrinol. 2011 Jul 4;47(1):R11-23. doi: 10.1530/JME-11-0004. Print 2011 Aug. J Mol Endocrinol. 2011. PMID: 21502284 Review.
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.
Bergaggio E, Riganti C, Garaffo G, Vitale N, Mereu E, Bandini C, Pellegrino E, Pullano V, Omedè P, Todoerti K, Cascione L, Audrito V, Riccio A, Rossi A, Bertoni F, Deaglio S, Neri A, Palumbo A, Piva R. Bergaggio E, et al. Among authors: pellegrino e. Blood. 2019 Jan 10;133(2):156-167. doi: 10.1182/blood-2018-05-850826. Epub 2018 Nov 19. Blood. 2019. PMID: 30455381 Free article.
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas.
Osella-Abate S, Mereu E, Pellegrino E, Bergaggio E, Ribero S, Bertero L, Lisa F, Fierro MT, Giulio Papotti M, Piva R. Osella-Abate S, et al. Among authors: pellegrino e. Oncol Lett. 2018 Dec;16(6):7091-7096. doi: 10.3892/ol.2018.9560. Epub 2018 Oct 9. Oncol Lett. 2018. PMID: 30546443 Free PMC article.
35 results